Market Access News | pharmaphorum

News

J&J claims FDA's latest national priority voucher

The FDA has awarded its latest national priority voucher to Johnson & Johnson for a combination regimen based on Tecvayli for multiple myeloma.

News

Sanofi gets double blow for MS drug tolebrutinib

Shares in Sanofi have slid on a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis.

News

GSK closes on approval of asthma hope depemokimab

GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.

News

CHMP decision levels the playing field for GSK's RSV jab

GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

News

Woman wears neuro headset for depression

FDA clears first at-home device for depression

Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.

J&J claims FDA's latest national priority voucher

Sanofi gets double blow for MS drug tolebrutinib

GSK closes on approval of asthma hope depemokimab

CHMP decision levels the playing field for GSK's RSV jab

UK teams up with Singapore on healthtech regulation

FDA clears first at-home device for depression

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks